A Medicine Supply Notification (MSN) for Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens has been issued.
There is limited supply until late May 2026, and the product is then expected to be out of stock until mid-June 2026.
Actions for clinicians
- Do not initiate new patients on Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens until the shortage has resolved.
- Review patients prescribed Trurapi® Solostar pens and where they have insufficient supplies to last until the re-supply date, consider prescribing the following alternatives until the shortage resolves:
- NovoRapid® Flexpen® (insulin aspart) 100units/ml pre-filled pen is the locally approved formulary option
- Trurapi® (insulin aspart) 100units/ml solution for injection 3ml cartridges with AllStar® PRO or JuniorSTAR® pens is an option but non-formulary in NCL.
- Ensure that patients are informed of the reason for the switch, and they may need to check their blood glucose levels more closely to ensure control.
- Provide patients with training on the use of their new device, signposting to videos (see supporting information links).
- Provide patients with the appropriate delivery device, needles and a sharps bin.
Seek advice from specialist diabetes teams on alternative management options if above is not appropriate.
ScriptSwitch® messages have been enabled to provide supporting information to prescribers. Further information is available on the NHS Specialist Pharmacy Service (login required) and refer to the MSN for full details.
